(Q73316253)
Statements
A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States (English)
T J Cicero
E H Adams
A Geller
J A Inciardi
A Muñoz
S H Schnoll
E C Senay
scientific article published on 01 November 1999